Odonate Therapeutics
Odonate, Inc., has no significant operations. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
Odonate Therapeutics (ODTC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2022: 0.054x
Based on the latest financial reports, Odonate Therapeutics (ODTC) has a cash flow conversion efficiency ratio of 0.054x as of December 2022.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($5.47 Million) by net assets ($100.85 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Odonate Therapeutics - Cash Flow Conversion Efficiency Trend (2015–2023)
This chart illustrates how Odonate Therapeutics's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Odonate Therapeutics Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Odonate Therapeutics ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GUANGDONG KANG.CO.LTD YC1
F:E9Q
|
N/A |
|
NKGen Biotech, Inc. Common Stock
PINK:NKGN
|
0.056x |
|
CT AUTOMOTIVE GROUP -005
F:X7X
|
N/A |
|
Boldt S.A
BA:BOLT
|
0.092x |
|
Keystone Reit Ltd
TA:KSTN
|
-0.007x |
|
Nico Resources Ltd
AU:NC1
|
0.020x |
|
Energy Plug Technologies Corp
OTCQB:PLGGF
|
-0.179x |
|
System1 Inc
NYSE:SST
|
-0.611x |
Annual Cash Flow Conversion Efficiency for Odonate Therapeutics (2015–2023)
The table below shows the annual cash flow conversion efficiency of Odonate Therapeutics from 2015 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $108.12 Million | $8.74 Million | 0.081x | +354.16% |
| 2022-12-31 | $100.85 Million | $1.79 Million | 0.018x | +101.39% |
| 2021-12-31 | $59.26 Million | $-75.72 Million | -1.278x | -53.77% |
| 2020-12-31 | $136.15 Million | $-113.13 Million | -0.831x | -39.56% |
| 2019-12-31 | $162.30 Million | $-96.64 Million | -0.595x | -10.05% |
| 2018-12-31 | $124.00 Million | $-67.09 Million | -0.541x | -310.08% |
| 2017-12-31 | $195.98 Million | $-25.86 Million | -0.132x | +82.62% |
| 2016-12-31 | $2.28 Million | $-1.73 Million | -0.759x | +48.93% |
| 2015-12-31 | $111.00K | $-165.00K | -1.486x | -- |